Gajić, S.; Janković, S.; Stojadinović, M.; Filić, K.; Bontić, A.; Pavlović, J.; Mrđa, I.; Petrović, K.; Hadži-Tanović, L.; Žunić, J.;
et al. The Effects of SGLT2 Inhibitors on Lipid Profile and Kidney Function in Patients with Chronic Kidney Disease Regardless of Diabetes and Hypertension Status. Metabolites 2025, 15, 271.
https://doi.org/10.3390/metabo15040271
AMA Style
Gajić S, Janković S, Stojadinović M, Filić K, Bontić A, Pavlović J, Mrđa I, Petrović K, Hadži-Tanović L, Žunić J,
et al. The Effects of SGLT2 Inhibitors on Lipid Profile and Kidney Function in Patients with Chronic Kidney Disease Regardless of Diabetes and Hypertension Status. Metabolites. 2025; 15(4):271.
https://doi.org/10.3390/metabo15040271
Chicago/Turabian Style
Gajić, Selena, Stefan Janković, Milorad Stojadinović, Kristina Filić, Ana Bontić, Jelena Pavlović, Ivana Mrđa, Kristina Petrović, Lara Hadži-Tanović, Jelena Žunić,
and et al. 2025. "The Effects of SGLT2 Inhibitors on Lipid Profile and Kidney Function in Patients with Chronic Kidney Disease Regardless of Diabetes and Hypertension Status" Metabolites 15, no. 4: 271.
https://doi.org/10.3390/metabo15040271
APA Style
Gajić, S., Janković, S., Stojadinović, M., Filić, K., Bontić, A., Pavlović, J., Mrđa, I., Petrović, K., Hadži-Tanović, L., Žunić, J., Kostić, M., Kezić, A., & Baralić, M.
(2025). The Effects of SGLT2 Inhibitors on Lipid Profile and Kidney Function in Patients with Chronic Kidney Disease Regardless of Diabetes and Hypertension Status. Metabolites, 15(4), 271.
https://doi.org/10.3390/metabo15040271
